cancer-related fatigue
Conditions
Interventions
Experimental group:ADQ807 granules
Control group:Placebo
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Women aged =18 years and =75 years; 2. Diagnosed with breast cancer according to Western medicine standards and in the consolidation phase; 3. Diagnosed with cancer-related fatigue; 4. Diagnosed with deficiency syndrome according to Traditional Chinese Medicine standards; 5. ECOG performance status (PS) =2; 6. Able to correctly understand the questions in the scale and complete the scale; 7. Voluntarily participate in this clinical study and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Pregnant or breastfeeding women; 2. Individuals with a history of other malignant tumors; 3. Patients with severe diseases of the heart brain liver kidneys and hematopoietic system liver function impairment and diabetes; 4. Individuals with a history of substance abuse of psychiatric drugs who cannot quit or have severe mental illnesses; 5. Patients with other life-threatening diseases deemed ineligible for enrollment by the researcher; 6. Individuals participating in other drug trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The revised Piper Fatigue Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional Assessment of Cancer Therapy-Breast;Cholic acid;TNF-a;TCM Syndrome Score Scale;IL-6;Fecal Intestinal Flora Tests;Serum metabolomics; | — |
Countries
China
Contacts
Public ContactZhiyu Wang
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed